Ondine Biomedical (OBI) Competitors C$13.25 +0.25 (+1.92%) As of 10/16/2025 05:06 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock OBI vs. BTG, ABC, GNS, ONT, OXB, ERGO, SLN, PRTC, HZD, and AVCTShould you be buying Ondine Biomedical stock or one of its competitors? The main competitors of Ondine Biomedical include BTG (BTG), Abcam (ABC), Genus (GNS), Oxford Nanopore Technologies (ONT), Oxford Biomedica (OXB), Ergomed (ERGO), Silence Therapeutics (SLN), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), and Avacta Group (AVCT). These companies are all part of the "biotechnology" industry. Ondine Biomedical vs. Its Competitors BTG Abcam Genus Oxford Nanopore Technologies Oxford Biomedica Ergomed Silence Therapeutics PureTech Health Horizon Discovery Group plc (HZD.L) Avacta Group Ondine Biomedical (LON:OBI) and BTG (LON:BTG) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations. Do institutionals & insiders hold more shares of OBI or BTG? 9.7% of Ondine Biomedical shares are owned by institutional investors. 37.4% of Ondine Biomedical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is OBI or BTG more profitable? BTG has a net margin of 0.00% compared to Ondine Biomedical's net margin of -873.84%. BTG's return on equity of 0.00% beat Ondine Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Ondine Biomedical-873.84% -684.01% -159.71% BTG N/A N/A N/A Does the media prefer OBI or BTG? In the previous week, BTG had 13 more articles in the media than Ondine Biomedical. MarketBeat recorded 13 mentions for BTG and 0 mentions for Ondine Biomedical. BTG's average media sentiment score of 0.22 beat Ondine Biomedical's score of 0.00 indicating that BTG is being referred to more favorably in the news media. Company Overall Sentiment Ondine Biomedical Neutral BTG Neutral Which has preferable valuation & earnings, OBI or BTG? BTG has higher revenue and earnings than Ondine Biomedical. Ondine Biomedical is trading at a lower price-to-earnings ratio than BTG, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOndine BiomedicalC$2.05M3,352.06-C$424.66K-C$0.07-189.29BTG£914.10M0.00N/A£28.50N/A SummaryBTG beats Ondine Biomedical on 8 of the 10 factors compared between the two stocks. Get Ondine Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for OBI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBI vs. The Competition Export to ExcelMetricOndine BiomedicalBiotechnology IndustryMedical SectorLON ExchangeMarket CapC$6.87BC$224.21MC$6.09BC$2.58BDividend YieldN/A3.81%5.73%5.32%P/E Ratio-189.2999.5085.084,414.48Price / Sales3,352.065,898.48604.99100,817.42Price / Cash1.9913.1937.8627.90Price / Book1,534.5299.1912.398.24Net Income-C$424.66K-C$90.99MC$3.32BC$5.89B7 Day Performance-1.85%0.72%2.31%0.36%1 Month Performance-11.67%6.09%9.68%2.38%1 Year Performance103.85%692.24%73.81%140.78% Ondine Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBIOndine BiomedicalN/AC$13.25+1.9%N/A+112.0%C$6.87BC$2.05M-189.29N/AGap UpBTGBTGN/AN/AN/AN/A£3.26B£914.10M29.474,690ABCAbcamN/AN/AN/AN/A£2.81B£350.40M20,433.331,650Gap UpHigh Trading VolumeGNSGenus1.3028 of 5 starsGBX 2,611.27+2.8%GBX 2,900+11.1%+29.6%£1.73B£672.80M9,035.53480ONTOxford Nanopore Technologies2.6819 of 5 starsGBX 150.50+0.8%GBX 245+62.8%+0.8%£1.45B£204.69M-1,016.891,281News CoverageOXBOxford Biomedica1.2094 of 5 starsGBX 653+0.8%GBX 558-14.5%+69.7%£784.95M£151.21M-1,802.87891ERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech HealthN/AGBX 134-0.6%GBX 455+239.6%-14.4%£323.86M£6.17M788.24300HZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416AVCTAvacta Group2.4331 of 5 starsGBX 71.36-0.9%GBX 99+38.7%+8.7%£291.32M£113K-406.58120 Related Companies and Tools Related Companies BTG Competitors Abcam Competitors Genus Competitors Oxford Nanopore Technologies Competitors Oxford Biomedica Competitors Ergomed Competitors Silence Therapeutics Competitors PureTech Health Competitors Horizon Discovery Group plc (HZD.L) Competitors Avacta Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:OBI) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ondine Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
